Literature DB >> 32632896

Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC).

Adriana Fonseca1, Samina Afzal2,3, Lynette Bowes4, Bruce Crooks2, Valerie Larouche5, Nada Jabado6, Sebastien Perreault7, Donna L Johnston8, Shayna Zelcer9, Adam Fleming10, Katrin Scheinemann10,11,12, Mariana Silva13, Magimairajan Issai Vanan14, Chris Mpofu15, Beverly Wilson16, David D Eisenstat16, Lucie Lafay-Cousin17, Juliette Hukin18, Cynthia Hawkins19, Ute Bartels19, Eric Bouffet19.   

Abstract

BACKGROUND: Diffuse intrinsic pontine gliomas (DIPG) are midline gliomas that arise from the pons and the majority are lethal within a few months after diagnosis. Due to the lack of histological diagnosis the epidemiology of DIPG is not completely understood. The aim of this report is to provide population-based data to characterize the descriptive epidemiology of this condition in Canadian children. PATIENTS AND METHODS: A national retrospective study of children and adolescents diagnosed with DIPG between 2000 and 2010 was undertaken. All cases underwent central review to determine clinical and radiological diagnostic characteristics. Crude incidence figures were calculated using age-adjusted (0-17 year) population data from Statistics Canada. Survival analyses were performed using the Kaplan-Meier method.
RESULTS: A total of 163 patients with pontine lesions were identified. Central review determined one-hundred and forty-three patients who met clinical, radiological and/or histological criteria for diagnosis. We estimate an incidence rate of 1.9 DIPG/1,000,000 children/year in the Canadian population over a 10 years period. Median age at diagnosis was 6.8 years and 50.3% of patients were female. Most patients presented with cranial nerve palsies (76%) and ataxia (66%). Despite typical clinical and radiological characteristics, histological confirmation reported three lesions to be low-grade gliomas and three were diagnosed as CNS embryonal tumor not otherwise specified (NOS).
CONCLUSIONS: Our study highlights the challenges associated with epidemiology studies on DIPG and the importance of central review for incidence rate estimations. It emphasizes that tissue biopsies are required for accurate histological and molecular diagnosis in patients presenting with pontine lesions and reinforces the limitations of radiological and clinical diagnosis in DIPG. Likewise, it underscores the urgent need to increase the availability and accessibility to clinical trials.

Entities:  

Keywords:  Brainstem tumors; Diffuse intrinsic pontine glioma (DIPG); Epidemiology; H3K27M

Mesh:

Year:  2020        PMID: 32632896     DOI: 10.1007/s11060-020-03568-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  31 in total

Review 1.  Diffuse brainstem tumors: when is a biopsy necessary?

Authors:  A L Albright
Journal:  Pediatr Neurosurg       Date:  1996       Impact factor: 1.162

2.  Is biopsy safe in children with newly diagnosed diffuse intrinsic pontine glioma?

Authors:  Stephanie Puget; Thomas Blauwblomme; Jacques Grill
Journal:  Am Soc Clin Oncol Educ Book       Date:  2012

3.  Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas.

Authors:  Stephanie Puget; Kevin Beccaria; Thomas Blauwblomme; Thomas Roujeau; Syril James; Jacques Grill; Michel Zerah; Pascale Varlet; Christian Sainte-Rose
Journal:  Childs Nerv Syst       Date:  2015-09-09       Impact factor: 1.475

4.  Brain stem gliomas of children. A clinicopathological study.

Authors:  A L Albright; R A Price; A N Guthkelch
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

Review 5.  Diffuse brainstem glioma in children: critical review of clinical trials.

Authors:  Darren Hargrave; Ute Bartels; Eric Bouffet
Journal:  Lancet Oncol       Date:  2006-03       Impact factor: 41.316

6.  Feasibility, safety, and indications for surgical biopsy of intrinsic brainstem tumors in children.

Authors:  Tene A Cage; Sonia P Samagh; Sabine Mueller; Theodore Nicolaides; Daphne Haas-Kogan; Michael Prados; Anu Banerjee; Kurtis I Auguste; Nalin Gupta
Journal:  Childs Nerv Syst       Date:  2013-05-11       Impact factor: 1.475

7.  K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas.

Authors:  Dong-Anh Khuong-Quang; Pawel Buczkowicz; Patricia Rakopoulos; Xiao-Yang Liu; Adam M Fontebasso; Eric Bouffet; Ute Bartels; Steffen Albrecht; Jeremy Schwartzentruber; Louis Letourneau; Mathieu Bourgey; Guillaume Bourque; Alexandre Montpetit; Genevieve Bourret; Pierre Lepage; Adam Fleming; Peter Lichter; Marcel Kool; Andreas von Deimling; Dominik Sturm; Andrey Korshunov; Damien Faury; David T Jones; Jacek Majewski; Stefan M Pfister; Nada Jabado; Cynthia Hawkins
Journal:  Acta Neuropathol       Date:  2012-06-03       Impact factor: 17.088

8.  Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications.

Authors:  Pawel Buczkowicz; Ute Bartels; Eric Bouffet; Oren Becher; Cynthia Hawkins
Journal:  Acta Neuropathol       Date:  2014-07-22       Impact factor: 17.088

9.  Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.

Authors:  Pawel Buczkowicz; Christine Hoeman; Patricia Rakopoulos; Sanja Pajovic; Louis Letourneau; Misko Dzamba; Andrew Morrison; Peter Lewis; Eric Bouffet; Ute Bartels; Jennifer Zuccaro; Sameer Agnihotri; Scott Ryall; Mark Barszczyk; Yevgen Chornenkyy; Mathieu Bourgey; Guillaume Bourque; Alexandre Montpetit; Francisco Cordero; Pedro Castelo-Branco; Joshua Mangerel; Uri Tabori; King Ching Ho; Annie Huang; Kathryn R Taylor; Alan Mackay; Anne E Bendel; Javad Nazarian; Jason R Fangusaro; Matthias A Karajannis; David Zagzag; Nicholas K Foreman; Andrew Donson; Julia V Hegert; Amy Smith; Jennifer Chan; Lucy Lafay-Cousin; Sandra Dunn; Juliette Hukin; Chris Dunham; Katrin Scheinemann; Jean Michaud; Shayna Zelcer; David Ramsay; Jason Cain; Cameron Brennan; Mark M Souweidane; Chris Jones; C David Allis; Michael Brudno; Oren Becher; Cynthia Hawkins
Journal:  Nat Genet       Date:  2014-04-06       Impact factor: 38.330

View more
  4 in total

1.  Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry.

Authors:  Margot A Lazow; Christine Fuller; Mariko DeWire; Adam Lane; Pratiti Bandopadhayay; Ute Bartels; Eric Bouffet; Sylvia Cheng; Kenneth J Cohen; Tabitha M Cooney; Scott L Coven; Hetal Dholaria; Blanca Diez; Kathleen Dorris; Moatasem El-Ayadi; Ayman El-Sheikh; Paul G Fisher; Adriana Fonseca; Mercedes Garcia Lombardi; Robert J Greiner; Stewart Goldman; Nicholas Gottardo; Sridharan Gururangan; Jordan R Hansford; Tim Hassall; Cynthia Hawkins; Lindsay Kilburn; Carl Koschmann; Sarah E Leary; Jie Ma; Jane E Minturn; Michelle Monje-Deisseroth; Roger Packer; Yvan Samson; Eric S Sandler; Gustavo Sevlever; Christopher L Tinkle; Karen Tsui; Lars M Wagner; Mohamed Zaghloul; David S Ziegler; Brooklyn Chaney; Katie Black; Anthony Asher; Rachid Drissi; Maryam Fouladi; Blaise V Jones; James L Leach
Journal:  Neuro Oncol       Date:  2022-05-04       Impact factor: 13.029

2.  Epidemiology of brainstem high-grade gliomas in children and adolescents in the United States, 2000-2017.

Authors:  Nirav Patil; Michael E Kelly; Debra Nana Yeboa; Robin A Buerki; Gino Cioffi; Sweta Balaji; Quinn T Ostrom; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300

3.  Brainstem gliomas … the devil is in the details.

Authors:  Adriana Fonseca; Eric Bouffet
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300

4.  Fifteen-year trends and differences in mortality rates across sex, age, and race/ethnicity in patients with brainstem tumors.

Authors:  Yusuke Tomita; Yoshihiro Tanaka; Nozomu Takata; Elizabeth A Hibler; Rintaro Hashizume; Oren Josh Becher
Journal:  Neurooncol Adv       Date:  2021-09-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.